Elixir Software Ltd
Paul F. is a seasoned professional in the field of computational chemistry and drug discovery, currently serving as CEO and Co-Founder of Elixir Software Ltd since June 2012. With over 70 years of collective industry experience from founding members, Elixir Software specializes in enhancing collaborations between pharmaceutical, biotech companies, and research organizations. Prior to this, Paul F. held positions as a Computational Chemist at AstraZeneca, focusing on oncology, and at GlaxoSmithKline, specializing in inflammatory diseases. Paul F. also contributed to molecular design at Tularik, working on inflammation and oncology projects. Paul F. holds a Doctor of Philosophy (PhD) in Computational Chemistry from The University of Manchester.
This person is not in any teams
This person is not in any offices
Elixir Software Ltd
Elixir Software provides software to improve the efficiency of teamwork in the scientific R&D community. Elixir created and continues to develop its core technology, iTraX; a real-time, web-based application used by managers and scientists to better plan, manage and track the delivery of work within scientific R&D projects.